To examine the possible role of TAS in NAFLD, we wanted to evaluate the JRE of TAS1R2, TAS1R3, TAS2R14 and TAS2R38 in a cohort with MO classified into NL and NAFLD groups. Here, TAS1R3 is linked to metabolic dysfunction-associated steatotic liver disease.